Document is current
Any future updates will be listed below
-
Authors
Jaremko, Jacob L.
Hareendranathan, Abhilash
Bolouri, Seyed Ehsan Seyed
Frey, Rod Fitzsimmons
Dulai, Sukhdeep
Bailey, Allan L.
-
Funding
Funding for this research was provided by:
Medical Imaging Consultants
Canada CIFAR AI Chair
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 20 May 2023
First Online: 7 June 2023
Competing interests
: Dr. Jacob L. Jaremko is a co-founder of MEDO.ai, which develops ultrasound imaging AI products including the Medo Hip app evaluated in this manuscript. He is also a partner of Medical Imaging Consultants and receives fees for interpreting medical imaging including hip ultrasound. Seyed Ehsan Bolouri and Rod Frey were employees of MEDO.ai at the time of this study. However, we have not received any funding from MEDO.ai for the feasibility study described in this paper. Dr. Hareendranathan and Rod Frey have been employees of MEDO.ai in the past, but are no longer working there and have no conflicts to declare. Drs. Dulai and Bailey have no conflicts. In 2022, MEDO.ai was acquired by Exo Inc, USA. Seyed Ehsan Bolouri is currently an employee of Exo Inc.
